首页> 外文OA文献 >Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature

【2h】

Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature

机译：利妥昔单抗，依托泊苷，甲基强的松龙，大剂量阿糖胞苷和顺铂治疗继发性吞噬性淋巴细胞组织细胞增生症并发经典霍奇金淋巴瘤：1例病例并文献复习

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Steve Hu; Pranshu Bansal; David Lynch; Cristhiam Mauricio Rojas Hernandez; Zoneddy Dayao;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC plus /-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas [J] . Tessoulin B., Thomare P., Delande E., Annals of hematology . 2017,第6期

机译：Carboplatin代替顺铂与地塞米松，具有或不含Rituximab（DHAC Plus / -R）的高剂量红霉（DHAC Plus / -R）的有效治疗，在霍奇金属和非Hodgkin的淋巴瘤中毒性低毒性
2. Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma. [J] . Mey UJ, Orlopp KS, Flieger D, Cancer investigation . 2006,第6期

机译：地塞米松，大剂量阿糖胞苷和顺铂联合利妥昔单抗作为挽救性治疗复发性或难治性侵袭性非霍奇金淋巴瘤的患者。
3. A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin's lymphoma. [J] . Sym SJ, Lee DH, Kang HJ, Cancer chemotherapy and pharmacology. . 2009,第1期

机译：依托泊苷，甲基泼尼松龙，大剂量阿糖胞苷和奥沙利铂的多中心II期试验用于原发性难治性/复发性侵袭性非霍奇金淋巴瘤患者。
4. Secondary coronary ectasia accompanied with EBV associated hemophagocytic lymphohistiocytosis: a case report and review of literature [C] . Huiyi Jiang, Wei Zhang, Jie Lei, International Conference on Medical Engineering and Bioinformatics . 2015

机译：副冠状动脉射向伴有EBV相关的血糖淋巴管菌症：一个案例报告和文学审查
5. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature [O] . Steve Hu, Pranshu Bansal, David Lynch, 2017

机译：利妥昔单抗，依托泊苷，甲基泼尼松龙，大剂量阿糖胞苷和顺铂治疗继发性吞噬性淋巴细胞组织细胞增生症并发经典霍奇金淋巴瘤：1例病例并文献复习
6. Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study [O] . Anton Hagenbeek, Hans Mooij, Josée Zijlstra, 2018

机译：Brentuximab-vEdotin与地塞米松，高剂量含有高剂量酸碱和顺铂相结合的I相剂量 - 升级研究，作为复发/难治性典型霍奇金淋巴瘤的救生处理：Hovon / LLPC移植勇敢的研究

Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature

著录项

相似文献

相关主题

期刊订阅